← Back to Discover
ARCH Venture Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,100,261,770
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PARABILIS MEDICINES INC · COM · 698955101 · shares: $175,517,789
- BEAM THERAPEUTICS INC · COM · 07373V105 · shares: $155,771,929
- RAPPORT THERAPEUTICS INC · COM · 75383L102 · shares: $155,376,512
- SEAPORT THERAPEUTICS INC · COMMON STOCK · 81221K108 · shares: $136,600,437
- ERASCA INC · COM · 29479A108 · shares: $129,917,324
- VIR BIOTECHNOLOGY INC · COM · 92764N102 · shares: $129,353,521
- MAZE THERAPEUTICS INC · COM · 578784100 · shares: $122,983,582
- LYELL IMMUNOPHARMA INC · COM NEW · 55083R203 · shares: $45,525,211
- GENERATE BIOMEDICINES INC · COM SHS · 370920100 · shares: $32,802,467
- 10X GENOMICS INC · CL A COM · 88025U109 · shares: $8,351,756
Reported holdings
12 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PARABILIS MEDICINES INC | COM | 698955101 | — | 6,412,780 shares | $175,517,789 |
| BEAM THERAPEUTICS INC | COM | 07373V105 | — | 4,540,132 shares | $155,771,929 |
| RAPPORT THERAPEUTICS INC | COM | 75383L102 | — | 3,728,738 shares | $155,376,512 |
| SEAPORT THERAPEUTICS INC | COMMON STOCK | 81221K108 | — | 6,294,951 shares | $136,600,437 |
| ERASCA INC | COM | 29479A108 | — | 7,091,557 shares | $129,917,324 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 12,694,163 shares | $129,353,521 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 4,120,053 shares | $122,983,582 |
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | — | 3,247,162 shares | $45,525,211 |
| GENERATE BIOMEDICINES INC | COM SHS | 370920100 | — | 1,944,426 shares | $32,802,467 |
| 10X GENOMICS INC | CL A COM | 88025U109 | — | 217,834 shares | $8,351,756 |
| BOUNDLESS BIO INC | COM | 10170A100 | — | 2,694,095 shares | $6,735,238 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 8,055,916 shares | $1,326,004 |